Pfizer

Haleon Posts Tepid Q1 Sales As Demand For Some Products Cool Off

Consumer healthcare company Haleon reported first-quarter revenue slightly below market estimates as volumes declined.

Pfizer To Cut Stake In Sensodyne Toothpaste-Maker Haleon To 24%

Consumer healthcare firm Haleon has said that U.S. drugmaker Pfizer, its top shareholder, will sell down its stake in the company to about 24%.

GSK Cuts Stake In Haleon To 7.4%, Raises £885.6m

British drugmaker GSK said it raised £885.6 million (€1 billion) from a discounted stake sale in Haleon, cutting its shareholding to 7.4%.

Sensodyne Toothpaste-Maker Haleon Planning Job Cuts - The Guardian

Haleon, the world's biggest standalone consumer health business, is planning to cut hundreds of roles in the UK and potentially thousands worldwide, the Gu...

GSK Sells $1bn Discounted Stake In Spin-Off Haleon

British drugmaker GSK on Friday sold 240 million shares in its consumer healthcare business Haleon at 335 pence per share, raising about £804 million...

Haleon First Quarter Profit Misses Analyst Expectations

Haleon, the world's biggest standalone consumer health business, has reported first-quarter profit below analyst expectations.

Pfizer Set To Exit GSK's Consumer Health Arm After Spin-Off

Pfizer plans to exit its 32% stake in Haleon, its consumer health joint venture with British drugmaker GSK, after the business is spun off as an independen...

GSK Rejects Elliott's Demands For Board, Consumer Business

GSK's board on Friday rejected Elliott's demands that the British company change its board and sell its consumer healthcare arm after separating it from it...